Sarah Barclay

Dr. Sarah Barclay

University of Calgary

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2018 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
SBSarah Barclay
Sarah Barclay
KIKyle W. Inman
Kyle W. Inman
VLValerie L. Luks
Valerie L. Luks
JMJohn B. McIntyre
John B. McIntyre
AAAlyaa Al-Ibraheemi
Alyaa Al-Ibraheemi
KKKyle C. Kurek
Kyle C. Kurek

25 August 2015 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
SBSarah Barclay
Sarah Barclay
CRCasey Rand
Casey Rand
LBLauren A. Borch
Lauren A. Borch
LNLisa Nguyen
Lisa Nguyen
PGPaul A. Gray
Paul A. Gray
NBN. Torben Bech-Hansen
N. Torben Bech-Hansen
Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) is thought to be a genetic disease caused by de novo mutations, though causative mutations have yet to be identified. We searched for de novo coding mutations among a carefully-diagnosed and clinically homogeneous cohort of 35 ROHHAD patients. We sequenced the exomes of seven ROHHAD trios, plus tumours from four of these patients and the unaffected monozygotic (MZ) twin of one (discovery cohort), to identify constitutional and somatic de novo sequence variants. We further analyzed this exome data to search for candidate genes under autosomal dominant and recessive models, and to identify structural variations. Candidate genes were tested by exome or Sanger sequencing in a replication cohort of 28 ROHHAD singletons. The analysis of the trio-based exomes found 13 de novo variants. However, no two patients had de novo variants in the same gene, and additional patient exomes and mutation analysis in the replication cohort did not provide strong genetic evidence to implicate any of these sequence variants in ROHHAD. Somatic comparisons revealed no coding differences between any blood and tumour samples, or between the two discordant MZ twins. Neither autosomal dominant nor recessive analysis yielded candidate genes for ROHHAD, and we did not identify any potentially causative structural variations. Clinical exome sequencing is highly unlikely to be a useful diagnostic test in patients with true ROHHAD. As ROHHAD has a high risk for fatality if not properly managed, it remains imperative to expand the search for non-exomic genetic risk factors, as well as to investigate other possible mechanisms of disease. In so doing, we will be able to confirm objectively the ROHHAD diagnosis and to contribute to our understanding of obesity, respiratory control, hypothalamic function, and autonomic regulation.

28 June 2014 in Hippocampus
Verified
Journal Article
Closed access
PDF file
GIGiuseppe Iaria
Giuseppe Iaria
AAAiden E.G.F. Arnold
Aiden E.G.F. Arnold
Ford BurlesFord Burles
Ford Burles
ILIrene Liu
Irene Liu
ESEdward Slone
Edward Slone
RLRichard M. Levy
Richard M. Levy

20 July 2018 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
SBSarah Barclay
Sarah Barclay
CRCasey Rand
Casey Rand
LNLisa Nguyen
Lisa Nguyen
RWRichard J. A. Wilson
Richard J. A. Wilson
RWRachel Wevrick
Rachel Wevrick
DWDebra E. Weese-Mayer
Debra E. Weese-Mayer
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) is a very rare and potentially fatal pediatric disorder, the cause of which is presently unknown. ROHHAD is often compared to Prader-Willi syndrome (PWS) because both share childhood obesity as one of their most prominent and recognizable signs, and because other symptoms such as hypoventilation and autonomic dysfunction are seen in both. These phenotypic similarities suggest they might be etiologically related conditions. We performed an in-depth clinical comparison of the phenotypes of ROHHAD and PWS and used NGS and Sanger sequencing to analyze the coding regions of genes in the PWS region among seven ROHHAD probands. Detailed clinical comparison of ROHHAD and PWS patients revealed many important differences between the phenotypes. In particular, we highlight the fact that the areas of apparent overlap (childhood-onset obesity, hypoventilation, autonomic dysfunction) actually differ in fundamental ways, including different forms and severity of hypoventilation, different rates of obesity onset, and different manifestations of autonomic dysfunction. We did not detect any disease-causing mutations within PWS candidate genes in ROHHAD probands. ROHHAD and PWS are clinically distinct conditions, and do not share a genetic etiology. Our detailed clinical comparison and genetic analyses should assist physicians in timely distinction between the two disorders in obese children. Of particular importance, ROHHAD patients will have had a normal and healthy first year of life; something that is never seen in infants with PWS.

10 May 2023 in Clinical Autonomic Research
Verified
Journal Article
Closed access
PDF file
IKIlya Khaytin Khaytin
Ilya Khaytin Khaytin
AVAnna Kaitlyn Victor
Anna Kaitlyn Victor
SBSarah Barclay
Sarah Barclay
LBLeslie A. Benson
Leslie A. Benson
SSSusan M. Slattery
Susan M. Slattery
DWDebra E. Weese-Mayer
Debra E. Weese-Mayer

1 January 2016 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
SBSarah Barclay
Sarah Barclay
CRCasey Rand
Casey Rand
PGPaul A. Gray
Paul A. Gray
WGWilliam T. Gibson
William T. Gibson
RWRichard J.A. Wilson
Richard J.A. Wilson
DWDebra E. Weese-Mayer
Debra E. Weese-Mayer